<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:circular="https://rhnvrm.github.io/stock-market-circulars/ns"><channel><title>Winsome - Stock Market Circulars</title><link>https://rhnvrm.github.io/stock-market-circulars/tags/winsome/</link><description>Regulatory circulars from NSE, BSE, and SEBI with AI-powered summaries</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Mon, 20 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://rhnvrm.github.io/stock-market-circulars/tags/winsome/feed.xml" rel="self" type="application/rss+xml"/><item><title>NSE Additional Surveillance Measure under IBC - April 2026 Update</title><link>https://rhnvrm.github.io/stock-market-circulars/circulars/nse/2026/nse-2026-04-20-f1699ce6a7f982b0-applicability-of-additional-surveillance-measure-under-ibc/</link><pubDate>Mon, 20 Apr 2026 00:00:00 +0530</pubDate><guid>https://rhnvrm.github.io/stock-market-circulars/circulars/nse/2026/nse-2026-04-20-f1699ce6a7f982b0-applicability-of-additional-surveillance-measure-under-ibc/</guid><description>NSE updates the Additional Surveillance Measure (ASM) list for companies under the Insolvency and Bankruptcy Code (IBC), adding Vivimed Labs Limited and removing Winsome Yarns Limited, effective April 21, 2026.</description><circular:source>nse</circular:source><circular:category>trading</circular:category><circular:impact>high</circular:impact><circular:severity>high</circular:severity><circular:importance>high</circular:importance><circular:id>f1699ce6a7f982b0</circular:id><circular:pdfUrl>https://nsearchives.nseindia.com/content/circulars/SURV73814.zip</circular:pdfUrl><circular:stock>VIVIMEDLAB</circular:stock><circular:stock>WINSOME</circular:stock><circular:stock>ABAN</circular:stock><circular:stock>AGSTRA</circular:stock><circular:stock>BILVYAPAR</circular:stock><category>surveillance</category><category>asm</category><category>ibc</category><category>insolvency</category><category>additional-surveillance-measure</category><category>vivimedlab</category><category>winsome</category><content:encoded><![CDATA[<h2 id="summary">Summary</h2>
<p>NSE has updated the Additional Surveillance Measure (ASM) list for companies under the Insolvency and Bankruptcy Code (IBC), effective April 21, 2026. Vivimed Labs Limited (VIVIMEDLAB) has been newly shortlisted under the &ldquo;Receipt of Corporate Announcement&rdquo; category, while Winsome Yarns Limited (WINSOME) has been excluded from the ASM-IBC framework.</p>
<h2 id="key-points">Key Points</h2>
<ul>
<li>VIVIMEDLAB (Vivimed Labs Limited, ISIN: INE526G01021) added to ASM-IBC under &ldquo;Receipt of corporate announcement / disclosure&rdquo; category effective April 21, 2026</li>
<li>WINSOME (Winsome Yarns Limited, ISIN: INE784B01035) excluded from ASM-IBC effective April 21, 2026</li>
<li>No securities moved between Stage I and Stage II in this update</li>
<li>ASM-IBC framework operates in conjunction with all other prevailing surveillance measures</li>
<li>Shortlisting is purely for market surveillance purposes and must not be construed as adverse action against any company</li>
</ul>
<h2 id="regulatory-changes">Regulatory Changes</h2>
<p>This circular is issued under the ASM-IBC framework established via prior circulars:</p>
<ul>
<li>NSE/SURV/37979 dated June 08, 2018</li>
<li>NSE/SURV/52368 dated May 20, 2022</li>
<li>NSE/SURV/55582 dated February 10, 2023</li>
<li>NSE/SURV/70074 dated September 05, 2025</li>
</ul>
<p>No structural changes to the ASM-IBC framework itself; this is a routine list update.</p>
<h2 id="compliance-requirements">Compliance Requirements</h2>
<ul>
<li>All NSE members must take note of the updated ASM-IBC securities list</li>
<li>Trading in VIVIMEDLAB will be subject to ASM-IBC restrictions (enhanced surveillance) from April 21, 2026</li>
<li>Members must ensure compliance with applicable trading restrictions for all securities on the consolidated ASM-IBC list</li>
<li>Queries may be directed to <a href="mailto:surveillance@nse.co.in">surveillance@nse.co.in</a></li>
</ul>
<h2 id="important-dates">Important Dates</h2>
<ul>
<li><strong>Circular Date:</strong> April 20, 2026</li>
<li><strong>Effective Date:</strong> April 21, 2026 (all changes to ASM-IBC list)</li>
</ul>
<h2 id="impact-assessment">Impact Assessment</h2>
<p><strong>VIVIMEDLAB (Vivimed Labs Limited):</strong> Addition to the ASM-IBC &ldquo;Receipt of Corporate Announcement&rdquo; category will subject this security to enhanced surveillance measures, potentially including additional margin requirements and trade restrictions. Investors and traders holding this stock should review applicable ASM conditions.</p>
<p><strong>WINSOME (Winsome Yarns Limited):</strong> Removal from ASM-IBC indicates the company has satisfied exclusion criteria, potentially easing trading restrictions and improving market liquidity for this security.</p>
<p><strong>Consolidated ASM-IBC List:</strong> The broader consolidated list continues to include securities such as ABAN (Aban Offshore Limited) and AGSTRA (AGS Transact Technologies Limited) at Stage I, among others. These remain subject to existing surveillance measures.</p>
<p>The ASM-IBC framework co-exists with other surveillance mechanisms, so affected securities may face cumulative restrictions from multiple overlapping measures.</p>
]]></content:encoded></item></channel></rss>